Although there is evidence to suggest that EPO has neuroprotective properties [69–71], the recently published results of the High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) trial (NCT02811263) did not demonstrate a neuroprotective effect [72]. The gene discussed is EPO; the disease is Encephalopathy.